Moreover, both DEHP and DBP inhibited the PI3K/AKT signaling pathway and led to impaired glucose transporters (GLUT2 and GLUT4), resulting in decreased glucose tolerance, insulin resistance, and hyperglycemia [86,87,88,89,97,98]. Here, SLC2A2 is linked to Insulin resistance.